Page 114 - Read Online
P. 114

veins in the dural border cell layer, causing them to   EBP is a feasible and efficient treatment for SIH with
           rupture and leading to subdural hematoma; (2) the   CSF leak in the cervical area, subdural hematoma and
           loss of CSF volume reduces absorption of CSF into the   CVT.
           cerebral venous sinuses, resulting in increased blood
                                             [5]
           viscosity in the venous compartment,  which could   CASE REPORT
           contribute to dural sinus thrombosis in patients with
           risk factors for thrombosis. The general consensus   A 48 years old Indian male presented with headache
           is that CVT should be treated with heparin, since a   and neck pain of 1 month duration. The patient had
           meta-analysis concluded that this treatment is safe   severe occipital headache with visual analogue score
           and is associated with a clinical trend (not statistically   of 9. The headache worsened in the upright position
           significant) of reduction in the  risk of death and   and  was completely relieved  after lying down. The
           dependency. Thus, most of the reported SIH patients   patient was otherwise normal, without any significant
           with CVT have been treated with anticoagulation so   past clinical history.
           far along with bed rest, hydration and epidural blood   On examination, the patient was conscious, oriented
           patches (EBP) [Table 2]. [6-14]  On the other hand, cases of   and afebrile, with a pulse rate of 82 beats per minute
           large subdural hemorrhage require surgical drainage   and blood pressure of 130/80 mmHg. Eye movements
           and treatment of the underlying cause of SIH. Most   were normal in all directions and there was no sign
           SIH  patients  without  other  complications  recover   of nystagmus. Both pupils were equal and reactive to
           after bed rest with foot end elevation, hydration and   light.  Cranial  nerve and  fundus examinations  were
           steroid therapy. Nevertheless, the mainstay of SIH   also normal and no motor weakness or sensory loss
           treatment is the  application of EBP at the  CSF-leak   was present. Flexor plantar response was positive and
           site (injection of 10-20  mL of autologous blood  into   bilateral. No signs of meningeal irritation nor focal
           the spinal  epidural  space). [15]   Relief of symptoms,   neurological deficits were found.
           particularly orthostatic  headache, is often dramatic
           after EBP, and if it fails it can be repeated. On the other   T2 weighted sequences from the MRI of the brain
           hand, direct EBP at the cervical area is challenging   showed bilateral symmetrical fronto-parietal and
           due to the narrow space of region and its proximity to   occipital subdural effusions [Figure 1A], while
           important neural structures, therefore, this treatment   T1 weighted sequences unveiled sagittal sinus
           is not performed in all cervical-leak cases. With this   thrombosis [Figure 1B]. T2  sequences from the
           case report we aimed to provide further evidence that   spine MRI revealed elliptical high signal extra axial
                                                               collection  posterior to  the spinal  cord  at  T3  to  T8
                                                               level, which was suggestive of CSF leak [Figure 2].

                                                               A lumbar puncture with CSF manometry was
                                                               performed under aseptic conditions, finding a CSF
                                                               opening pressure of 50 mmH O. CSF content analysis
                                                                                         2
                                                               [Table 1] showed elevated proteins [normal CSF
                                                               protein ranges from 20-40 mg/dL]. CT myelography
                                                               revealed extradural contrast extravasation at C2-C3
                                                               level [Figure 3A].

                                                               Vasculitic work-up yielded negative results for anti-
                                                               nuclear antibody, anti-double stranded DNA antibody,
                                                               perinuclear anti-neutrophil  cytoplasmic antibody,
                                                               cytoplasmic anti-neutrophil cytoplasmic antibody
                                                               and anti-phospholipid antibody. Thrombophilia
                                                               screening resulted also negative, as anti-thrombin,
                                                               protein C and protein S were normal. Factor V Leiden

                                                               Table 1: Cerebrospinal fluid analysis
                                                               Parameters    Results
                                                               CSF colour    Clear fluid, no xanthochromia, no turbidity
                                                               CSF pressure  50 mmH 2 O
                                                               CSF protein   315 mg/dL
           Figure 1: MRI brain. (A) T2 weighted sequences  showing bilateral symmetrical   CSF sugar  93 mg/dL
           fronto-parietal and occipital subdural effusions (as marked by the arrow); (B)   CSF cell count  Occassional RBCs only
           T1 weighted sequences showing saggital sinus thrombosis (as marked by the
           arrow)                                             CSF: cerebrospinal fluid; RBCs: red blood cells


           Neuroimmunol Neuroinflammation | Volume 3 | April 19, 2016                                       105
   109   110   111   112   113   114   115   116   117   118   119